Combination of Uric Acid and NT-ProBNP: A More Useful Prognostic Marker for Short-Term Clinical Outcomes in Patients with Acute Heart Failure
![]() |
Park, Hyoung-Seob
(Department of Internal Medicine, Keimyung University School of Medicine)
Kim, Hyung-Seop (Department of Internal Medicine, Keimyung University School of Medicine) Sohn, Ji-Hyun (Department of Internal Medicine, Keimyung University School of Medicine) Shin, Hong-Won (Department of Internal Medicine, Keimyung University School of Medicine) Cho, Yun-Kyeong (Department of Internal Medicine, Keimyung University School of Medicine) Yoon, Hyuck-Jun (Department of Internal Medicine, Keimyung University School of Medicine) Nam, Chang-Wook (Department of Internal Medicine, Keimyung University School of Medicine) Hur, Seung-Ho (Department of Internal Medicine, Keimyung University School of Medicine) Kim, Yoon-Nyun (Department of Internal Medicine, Keimyung University School of Medicine) Kim, Kwon-Bae (Department of Internal Medicine, Keimyung University School of Medicine) Park, Hee-Joon (Department of Medical Informatics, Keimyung University School of Medicine) |
1 | Doehner W, von Haehling S, Anker SD. Uric acid as a prognostic marker in acute heart failure: new expectations from an old molecule. Eur J Heart Fail 2007;9:437-439. DOI ScienceOn |
2 | Landmesser U, Spiekermann S, Dikalov S, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002;106:3073-3078. DOI ScienceOn |
3 | Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971- 1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-2410. DOI ScienceOn |
4 | Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:1503-1507. DOI ScienceOn |
5 | Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail 2006;12:491-498. DOI ScienceOn |
6 | Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-234. DOI |
7 | Pascual-Figal DA, Hurtado-Martínez JA, Redondo B, et al. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007;9:518-524. DOI ScienceOn |
8 | Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41. DOI |
9 | Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-1997. DOI ScienceOn |
10 | Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416. DOI ScienceOn |
11 | Leyva F, Chua TP, Anker SD, et al. Uric acid in chronic heart failure: a measure of the anaerobic threshold. Metabolism 1998;47:1156-1159. DOI ScienceOn |
12 | Leyva F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858-865. DOI ScienceOn |
13 | Sakai H, Tsutamoto T, Tsutsui T, et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J 2006;70:1006-1011. DOI ScienceOn |
14 | Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-2411. DOI ScienceOn |
15 | Mazza A, Pessina AC, Pavei A, et al. Predictors of stroke mortality in elderly people from the general population: the cardiovascular study in the elderly. Eur J Epidemiol 2001;17:1097-1104. DOI ScienceOn |
16 | Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-1283. DOI ScienceOn |
17 | Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587-1593. DOI ScienceOn |
18 | Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006;47:91-97. DOI ScienceOn |
19 | Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-1956. DOI ScienceOn |
20 | Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735. DOI ScienceOn |
21 | Song BG, Jeon ES, Kim YH, et al. Correlation between levels of Nterminal pro-B-type natriuretic peptide and degrees of heart failure. Korean J Intern Med 2005;20:26-32. DOI ScienceOn |
22 | Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-2174. DOI ScienceOn |
23 | Gardner RS, Ozalp F, Murday AJ, et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743. DOI ScienceOn |
24 | Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1995;141:637-644. |
25 | Niskanen LK, Laaksonen DE, Nyyssönen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-1551. DOI ScienceOn |
26 | Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 2000;36:1072-1078. DOI ScienceOn |
![]() |